Search company, investor...

Tikvah Therapeutics

Founded Year



Convertible Note | Alive

About Tikvah Therapeutics

Tikvah Therapeutics is a company based in Atlanta, Georgia. Tikvah Therapeutics has received investment from Advanced Technology Development Center.

Headquarters Location

75 Fifth Street, NW Suite 207

Atlanta, Georgia, 30308,

United States

Missing: Tikvah Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Tikvah Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Tikvah Therapeutics News

Tikvah Raises $10 Million - Advanced Technology Development Center

May 23, 2016

Login Tikvah Raises $10 Million ATDC member company Tikvah Therapeutics, Inc , a biopharmaceutical company that focuses on novel therapeutic treatments for diseases of the central nervous system, including neurology and psychiatric disorders, announced today it has completed a private financing with gross proceeds of $10 million in a convertible note financing. Proceeds from the financing will be used to accelerate development of the company’s lead products. "This financing provides us with resources to continue the planned advancement of Tikvah’s robust pipeline of central nervous system and neurology drug candidates," said Dr. Harold H. Shelvin, President and CEO of Tikvah. "In the coming months, we plan to move forward with Investigational New Drug applications for our two lead products as well as continue to vigorous acquisition of additional later stage and pipeline products. "

Tikvah Therapeutics Frequently Asked Questions (FAQ)

  • When was Tikvah Therapeutics founded?

    Tikvah Therapeutics was founded in 2006.

  • Where is Tikvah Therapeutics's headquarters?

    Tikvah Therapeutics's headquarters is located at 75 Fifth Street, NW, Atlanta.

  • What is Tikvah Therapeutics's latest funding round?

    Tikvah Therapeutics's latest funding round is Convertible Note.

  • Who are the investors of Tikvah Therapeutics?

    Investors of Tikvah Therapeutics include Paramount BioCapital Asset Management and Advanced Technology Development Center.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.